Sudhir Agrawal D.phil

Sudhir Agrawal D.Phil, FRSC is a distinguished scientist and entrepreneur with extensive experience in the biotechnology sector. Currently, Sudhir serves as the Founder and President of ARNAY Sciences since October 2017, and holds co-founding and advisory roles at several innovative companies, including Aldebaran Therapeutics and Alloy Therapeutics, Inc. Additionally, Sudhir contributes to multiple scientific advisory boards, including those of QurAlis, Dyne Therapeutics, SynGenis, HAYA Therapeutics SA, and Quiver Bioscience. In academia, Sudhir is affiliated as a Professor in the Department of Medicine at UMass Chan Medical School, while also serving as a visiting professor. Sudhir's educational background includes post-doctoral research at the MRC Laboratory of Molecular Biology in Cambridge, UK, and degrees in Organic Chemistry from Allahabad University, India.